Skip to main content
. 2021 Dec 13;12(2):381–393. doi: 10.1007/s13555-021-00661-2
Why carry out this study?
The rarity of GPP makes it impossible for all clinical centres to develop an adequate level of experience in the management of this disease.
Thirteen practising dermatologists from 10 countries across five regions attended a virtual workshop to share experiences in managing patients with GPP and identify educational needs and clinical practice gaps.
What was learned from the study?
The most important educational imperative identified by the workshop participants was that both non-dermatologists and dermatologists should appreciate that GPP can be life-threatening if the initiation of correct treatment is delayed and understand when to refer patients with GPP to a specialist for diagnosis and/or treatment and ongoing management.
Academic- and community-based practices that regularly care for patients with GPP should strive to learn from their experiences and collaborate with less experienced clinical centres to help ensure the delivery of consistent, best-practice treatment.